Skip to content

Investigating the comparison therapeutic effect of 5% saline versus 3% in the hospitalized patient with Acute Bronchiolitis.

Investigating the comparison therapeutic effect of 5% saline versus 3% in the hospitalized patient with Acute Bronchiolitis.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181006041252N4
Enrollment
94
Registered
2018-12-31
Start date
2018-12-26
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Bronchiolitis. Acute Bronchiolitis

Interventions

Intervention 1: ?Intervention group: Patients in this group received 0.15 mg/kg Salbutamol and 5 cc nebulizer saline 5% and 8 liters of oxygen per minute while receiving nebulizers. Intervention 2: ?I

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 24 Months

Inclusion criteria

Inclusion criteria: Children aged 1 to 24 months with moderate to severe Bronchiolitis and clinical scores >= 4

Exclusion criteria

Exclusion criteria: The presence of underlying disease (cystic fibrosis, congenital heart disease, immune deficiency) Get antibiotics before studying Get Cortisone Inhaled and Systemic Recent use of bronchodilators History of immaturity and gestational age less than 32 weeks Chronic pulmonary disease History of NICU admission

Design outcomes

Primary

MeasureTime frame
Determine the Modified Respiratory Assessment Score (MRAS). Timepoint: At the beginning of the study (before the intervention) and daily until discharge. Method of measurement: Using the modified respiratory assessment score.

Secondary

MeasureTime frame
Determine the respiratory sounds (Vising). Timepoint: At the beginning of the study (before the intervention) and daily until discharge. Method of measurement: Auscultation of the lungs with Stethoscope.;Respiratory Rate. Timepoint: At the beginning of the study (before the intervention) and daily until discharge. Method of measurement: The number of chest or abdominal cramps in 15 seconds or 1 minute.;Determine the level of peripheral capillary oxygen saturation (SPO2). Timepoint: At the beginning of the study (before the intervention) and daily until discharge. Method of measurement: Pulse Oximeter or Oxygenometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Alireza Asadi

Sabzevar University of Medical Sciences

dralirezaasadi@gmail.com+98 51 4401 1604

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026